NO140304C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-olerInfo
- Publication number
- NO140304C NO140304C NO528/73A NO52873A NO140304C NO 140304 C NO140304 C NO 140304C NO 528/73 A NO528/73 A NO 528/73A NO 52873 A NO52873 A NO 52873A NO 140304 C NO140304 C NO 140304C
- Authority
- NO
- Norway
- Prior art keywords
- 16alfa
- 15alfa
- oestrene
- 17beta
- oles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2207421A DE2207421C3 (de) | 1972-02-11 | 1972-02-11 | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO140304B NO140304B (no) | 1979-04-30 |
| NO140304C true NO140304C (no) | 1979-08-08 |
Family
ID=5836211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO528/73A NO140304C (no) | 1972-02-11 | 1973-02-09 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler |
| NO782754A NO143065C (no) | 1972-02-11 | 1978-08-14 | Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO782754A NO143065C (no) | 1972-02-11 | 1978-08-14 | Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler |
Country Status (29)
| Country | Link |
|---|---|
| JP (1) | JPS5829317B2 (ro) |
| KR (1) | KR780000156B1 (ro) |
| AT (1) | AT327413B (ro) |
| AU (1) | AU467306B2 (ro) |
| BE (1) | BE795241A (ro) |
| CA (1) | CA997753A (ro) |
| CH (2) | CH593995A5 (ro) |
| CS (1) | CS193019B2 (ro) |
| DD (1) | DD102379A5 (ro) |
| DE (1) | DE2207421C3 (ro) |
| DK (1) | DK131037B (ro) |
| EG (1) | EG10914A (ro) |
| ES (1) | ES410933A1 (ro) |
| FI (1) | FI52225C (ro) |
| FR (1) | FR2181719B1 (ro) |
| GB (1) | GB1425636A (ro) |
| GR (1) | GR63160B (ro) |
| HU (1) | HU165253B (ro) |
| IE (1) | IE37266B1 (ro) |
| IL (1) | IL41506A (ro) |
| NL (1) | NL177217C (ro) |
| NO (2) | NO140304C (ro) |
| PH (1) | PH9370A (ro) |
| PL (1) | PL81084B1 (ro) |
| RO (1) | RO73527A (ro) |
| SE (3) | SE403781B (ro) |
| SU (1) | SU513628A3 (ro) |
| YU (1) | YU35035B (ro) |
| ZA (1) | ZA73944B (ro) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007027637A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027636A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT274653B (de) * | 1966-11-10 | 1969-09-25 | Alexander Schoeller & Co Kg | Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten |
-
0
- BE BE795241D patent/BE795241A/xx not_active IP Right Cessation
-
1972
- 1972-02-11 DE DE2207421A patent/DE2207421C3/de not_active Expired
- 1972-12-29 PL PL1972159970A patent/PL81084B1/pl unknown
-
1973
- 1973-01-11 DD DD168198A patent/DD102379A5/xx unknown
- 1973-01-16 DK DK24273AA patent/DK131037B/da not_active IP Right Cessation
- 1973-01-23 FI FI730169A patent/FI52225C/fi active
- 1973-01-24 ES ES410933A patent/ES410933A1/es not_active Expired
- 1973-01-31 CS CS73748A patent/CS193019B2/cs unknown
- 1973-01-31 YU YU243/73A patent/YU35035B/xx unknown
- 1973-02-06 IE IE190/73A patent/IE37266B1/xx unknown
- 1973-02-06 CA CA163,029A patent/CA997753A/en not_active Expired
- 1973-02-07 EG EG49/73A patent/EG10914A/xx active
- 1973-02-08 AT AT112473A patent/AT327413B/de not_active IP Right Cessation
- 1973-02-09 FR FR7304678A patent/FR2181719B1/fr not_active Expired
- 1973-02-09 IL IL41506A patent/IL41506A/en unknown
- 1973-02-09 GR GR1318A patent/GR63160B/el unknown
- 1973-02-09 CH CH535776A patent/CH593995A5/xx not_active IP Right Cessation
- 1973-02-09 SU SU1891803A patent/SU513628A3/ru active
- 1973-02-09 PH PH14330*UA patent/PH9370A/en unknown
- 1973-02-09 NO NO528/73A patent/NO140304C/no unknown
- 1973-02-09 ZA ZA730944A patent/ZA73944B/xx unknown
- 1973-02-09 CH CH186373A patent/CH590883A5/xx not_active IP Right Cessation
- 1973-02-10 HU HUSE1666A patent/HU165253B/hu unknown
- 1973-02-10 RO RO7373805A patent/RO73527A/ro unknown
- 1973-02-10 KR KR7300246A patent/KR780000156B1/ko active
- 1973-02-12 SE SE7301935A patent/SE403781B/xx unknown
- 1973-02-12 JP JP48017357A patent/JPS5829317B2/ja not_active Expired
- 1973-02-12 GB GB682173A patent/GB1425636A/en not_active Expired
- 1973-02-12 NL NLAANVRAGE7301974,A patent/NL177217C/xx not_active IP Right Cessation
- 1973-02-12 AU AU52076/73A patent/AU467306B2/en not_active Expired
-
1975
- 1975-12-22 SE SE7514513A patent/SE409329B/xx not_active IP Right Cessation
-
1977
- 1977-12-07 SE SE7713896A patent/SE426834B/sv not_active IP Right Cessation
-
1978
- 1978-08-14 NO NO782754A patent/NO143065C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
| NO140589C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 3,4-dihydrokarbostyrilderivater | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
| NO144743C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater | |
| NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
| NO142865C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
| NO137782C (no) | Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer | |
| NO142033C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO138599C (no) | Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater | |
| NO141648C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater | |
| NO140348C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser | |
| NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
| NO140858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO138660C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 3-(piperazinalkyl)-2,4-kinazolindioner | |
| FI49827C (fi) | Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi. | |
| NO740411L (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on. | |
| NO136840C (no) | Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin | |
| NO141555C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme dibenzocykloheptenkarboksamider | |
| NO137548C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive n-difenylpropyl-propylendiaminer | |
| NO138568C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon |